Leber L, Beaudet A, Muller A. Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension:0 identification of the most accurate estimates from a systematic literature review. Pulm Circ. 2021. https://doi.org/10.1177/2045894020977300.

Article  PubMed  PubMed Central  Google Scholar 

Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S, ESC/ERS Scientific Document Group. 2022 Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2023. https://doi.org/10.1183/13993003.00879-2022.

Article  PubMed  PubMed Central  Google Scholar 

Humbert M, Guignabert C, Bonnet S, Dorfmüller P, Klinger JR, Nicolls MR, Olschewski AJ, Pullamsetti SS, Schermuly RT, Stenmark KR, Rabinovitch M. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. ERJ. 2019. https://doi.org/10.1183/13993003.01887-2018.

Article  Google Scholar 

Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173(9):1023–30.

Article  PubMed  Google Scholar 

Hoeper MM, Huscher D, Pittrow D. Incidence and prevalence of pulmonary hypertension in Germany. Int J Cardiol. 2016;203:612–3.

Article  PubMed  Google Scholar 

Chang KY, Duval S, Badesch DB, Bull TM, Chakinala MM, De Marco T, Frantz RP, Hemnes A, Mathai SC, Rosenzweig EB, Ryan JJ, Thenappan T, PHAR Investigators. Mortality in pulmonary arterial hypertension in the modern era: early insights from the pulmonary hypertension association registry. J Am Heart Assoc. 2022. https://doi.org/10.1161/JAHA.121.024969.

Article  PubMed  PubMed Central  Google Scholar 

Boucly A, Weatherald J, Savale L, de Groote P, Cottin V, Prévot G, Chaouat A, Picard F, Horeau-Langlard D, Bourdin A, Jutant EM, Beurnier A, Jevnikar M, Jaïs X, Simonneau G, Montani D, Sitbon O, Humbert M. External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry. Eur Respir J. 2022. https://doi.org/10.1183/13993003.02419-2021.

Article  PubMed  PubMed Central  Google Scholar 

Guignabert C, Humbert M. Targeting transforming growth factor-β receptors in pulmonary hypertension. Eur Resp J. 2021. https://doi.org/10.1183/13993003.02341-2020.

Article  Google Scholar 

Dunmore BJ, Jones RJ, Toshner MR, Upton PD, Morrell NW. Approaches to treat pulmonary arterial hypertension by targeting BMPR 2: from cell membrane to nucleus. Cardiovasc Res. 2021;117(11):2309–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yung LM, Yang P, Joshi S, Augur ZM, Kim SSJ, Bocobo GA, Dinter T, Troncone L, Chen PS, McNeil ME, Southwood M, Poli de Frias S, Knopf J, Rosas IO, Sako D, Pearsall RS, Quisel JD, Li G, Kumar R, Yu PB. ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension. Sci Transl Med. 2020. https://doi.org/10.1126/scitranslmed.aaz5660.

Article  PubMed  PubMed Central  Google Scholar 

Humbert M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, Souza R, Waxman A, Escribano Subias P, Feldman J, Meyer G, Montani D, Olsson KM, Manimaran S, Barnes J, Linde PG, de Oliveira PJ, Badesch DB, PULSAR Trial Investigators. Sotatercept for the treatment of pulmonary arerial hypertension. N Engl J Med. 2021;384(13):1204–15.

Article  CAS  PubMed  Google Scholar 

Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Souza R, Waxman AB, Grünig E, Kopeć G, Meyer G, Olsson KM, Rosenkranz S, Xu Y, Miller B, Fowler M, Butler J, Koglin J, de Oliveira Pena J, Humbert M. STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388(16):1478–90.

Article  CAS  PubMed  Google Scholar 

Derynck R, Budi EH. Specificity, versatility, and control of TGF-β family signaling. Sci Signal. 2019. https://doi.org/10.1126/scisignal.aav5183.

Article  PubMed  PubMed Central  Google Scholar 

Morikawa M, Derynck R, Miyazono K. TGF-β and the TGF-β family: Context-dependent roles in cell and tissue physiology. Cold Spring Harb Perspect Biol. 2016. https://doi.org/10.1101/cshperspect.a021873.

Article  PubMed  PubMed Central  Google Scholar 

Heldin CH, Moustakas A. Signaling receptors for TGF-β family members. Cold Spring Harb Perspect Biol. 2016. https://doi.org/10.1101/cshperspect.a022053.

Article  PubMed  PubMed Central  Google Scholar 

Chang C. Agonists and antagonists of TGF-β family ligand. Cold Spring Harb Perspect Biol. 2016. https://doi.org/10.1101/cshperspect.a021923.

Article  PubMed  PubMed Central  Google Scholar 

Yang X, Long L, Southwood M, Rudarakanchana N, Upton PD, Jeffery TK, Atkinson C, Chen H, Trembath RC, Morrell NW. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circ Res. 2005;96(10):1053–63.

Article  CAS  PubMed  Google Scholar 

Massagué J. TGF-β signalling in context. Nat Rev Mol Cell Biol. 2012;13:616–30.

Article  PubMed  PubMed Central  Google Scholar 

Hata A, Chen YG. TGF-B signaling from receptors to smad. Cold Spring Harb Perspect Biol. 2016. https://doi.org/10.1101/cshperspect.a022061.

Article  PubMed  PubMed Central  Google Scholar 

Ma L, Chung WK. The role of genetics in pulmonary arterial hypertension. J Pathol. 2017;241:273–80.

Article  CAS  PubMed  Google Scholar 

Swietlik EM, Prapa M, Martin JM, Pandya D, Aukland K, Morrell NW, Gräf S. ‘There and back again’-Forward genetics and reverse phenotyping in pulmonary arterial hypertension. Genes. 2020. https://doi.org/10.3390/genes11121408.

Article  PubMed  PubMed Central  Google Scholar 

Upton PD, Davies RJ, Trembath RC, Morrell NW. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells. J Biol Chem. 2009;284:15794–804.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spiekerkoetter E, Tian X, Cai J, Hopper RK, Sudheendra D, Li CG, El-Bizri N, Sawada H, Haghighat R, Chan R, Haghighat L, Perez V, Wang L, Teddy S, Zhao M, Bernstein D, Solow-Cordero DE, Beachy PA, Wandless TJ, Dijke P, Rabinovitch M. FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. JCI. 2013;123(8):3600–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dunmore BJ, Drake KM, Upton PD, Toshner MR, Aldred MA, Morrell NW. The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signaling in endothelial cells harbouring BMP-II mutations. Hum Mol Genet. 2013;22(18):3667–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Long L, Yang X, Southwood M, Lu J, Marciniak SJ, Dunmore BJ, Morrell NW. Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation. Circ Res. 2013;112(8):1159–70.

Article  CAS  PubMed  Google Scholar 

Reynolds AM, Xia W, Holmes MD, Hodge SJ, Danilov S, Curiel DT, Morrell NM, Reynolds PN. Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1182–92.

Article  CAS  PubMed  Google Scholar 

Yu PB, Deng DY, Beppu H, Hong CC, Lai C, Hoyng SA, Kawai N, Bloch KD. Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells. J Biol Chem. 2008;283:3877–88.

Article  CAS  PubMed